Back to results
US 12,215,087 B2Granted
Inhibitors of NLRP3 inflammasome
AssigneeBioAge Labs, Inc.
InventorsGeorge Hartman, Paul Humphries, Kevin Edward Leif Wilhelmsen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
Claims6
A compound that is
- or a pharmaceutically acceptable salt thereof.
A compound that is
- or a pharmaceutically acceptable salt thereof.
A compound that is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.